Jenburkt Pharmaceuticals has informed that the company proposed to transact a Special Resolution of approval of terms of remuneration of the Chairman and Managing Director of the Company, pursuant to the amendment in the Companies Act, 2013 by way of postal ballot route, kindly find attached a soft copy of Notice and Form of Postal Ballot in this regard, in pursuance of Regulation 30 of LODR. The Postal Ballot commenced at 9.00 am on 29th December, 2018 and shall end at 5.00 pm on 28th January, 2019. The Shareholders have been provided with option to vote electronically. CDSL has been appointed as a service provider in this regard.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1850.40 |
| Dr. Reddys Lab | 1310.50 |
| Cipla | 1365.25 |
| Zydus Lifesciences | 939.10 |
| Lupin | 2442.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: